Armistice Capital, LLC 13D and 13G filings for Catalyst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:27 pm Sale |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Armistice Capital, LLC | 0 0.000% |
-9,572,000 (Position Closed) |
Filing |
| 2022-02-14 6:28 pm Sale |
2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Armistice Capital, LLC | 9,572,000 9.300% |
-428,000 (-4.28%) |
Filing |
| 2021-02-16 2:59 pm Purchase |
2020-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Armistice Capital, LLC | 10,000,000 9.700% |
4,622,000 (+85.94%) |
Filing |